Crossmark

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Crossref DOI link: https://doi.org/10.1186/s40364-018-0145-8

Published Online: 2018-10-30

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Agnoletto, Chiara

Minotti, Linda

Brulle-Soumare, Laura

Pasquali, Lorenzo

Galasso, Marco

Corrà, Fabio

Baldassari, Federica

Judde, Jean-Gabriel

Cairo, Stefano

Volinia, Stefano
Funding

Funding for this research was provided by:

Associazione Italiana Ricerca sul Cancro AIRC (IG 17063)

PRIN MIUR 2010 (2010W4J4RM)
License Information

Text and Data Mining valid from 2018-10-30
More Information

Article History

Received: 18 July 2018

Accepted: 1 October 2018

First Online: 30 October 2018

Ethics approval and consent to participate

: Blood was collected from mice with tumours reaching the ethical size and eventually sacrificed in compliance with the indications provided in the protocol #6194 approved by the CE51 animal ethical committee at CERFE animal facility and by the French Ministry of agriculture food and forestry.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.